Search research articles
Contact Us
Filters
Showing results (431-440 of 577) with videos related to
Page
of 58
Sort By:
Chemmedchem
|
January 18, 2019
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic Probe
Mansura Akter, Nyssa Drinkwater, Shane M Devine, et al.
Bone Marrow Transplantation
|
July 29, 2014
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma
S M Jaglowski, A S Ruppert, C C Hofmeister, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Transplantation and Cellular Therapy
|
October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023
Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
Bone Marrow Transplantation
|
October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant
S M Devine, R Sanborn, E Jessop, et al.
FEBS Letters
|
September 29, 2009
A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex
Xiang Li, Ruth MacLeod, Allan J Dunlop, et al.
British Journal of Haematology
|
July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Samantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Journal of Medicinal Chemistry
|
March 16, 1992
Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation
T W von Geldern, T W Rockway, S K Davidsen, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Blood Advances
|
March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
Firas El Chaer, Uma Borate, Rémy Duléry, et al.
Page
of 58
Search research articles
Search
Showing results (431-440 of 577) with videos related to
Sort By:
Page
of 58
Chemmedchem
|
January 18, 2019
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic Probe
Mansura Akter, Nyssa Drinkwater, Shane M Devine, et al.
Bone Marrow Transplantation
|
July 29, 2014
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma
S M Jaglowski, A S Ruppert, C C Hofmeister, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Transplantation and Cellular Therapy
|
October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023
Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
Bone Marrow Transplantation
|
October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant
S M Devine, R Sanborn, E Jessop, et al.
FEBS Letters
|
September 29, 2009
A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex
Xiang Li, Ruth MacLeod, Allan J Dunlop, et al.
British Journal of Haematology
|
July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Samantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Journal of Medicinal Chemistry
|
March 16, 1992
Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation
T W von Geldern, T W Rockway, S K Davidsen, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Blood Advances
|
March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
Firas El Chaer, Uma Borate, Rémy Duléry, et al.
Page
of 58